Eloxx Pharmaceuticals Inc (OTCPK:ELOX)
$ 0.68557 -0.05443 (-7.36%) Market Cap: 2.15 Mil Enterprise Value: 3.31 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 34/100

Eloxx Pharmaceuticals Inc Annual Shareholders Meeting Transcript

May 20, 2020 / 05:00PM GMT
Release Date Price: $135.6 (+8.65%)
Gregory Williams
Eloxx Pharmaceuticals, Inc. - CEO & Director

Welcome to the Eloxx Pharmaceuticals Annual Meeting of Stockholders. I'm Greg Williams, Chief Executive Officer of Eloxx Pharmaceuticals. Also joining me on the line today is our Chief Operating Officer, General Counsel and Corporate Secretary, Neil Belloff. I will be serving as the Chair of the meeting, and Mr. Belloff will be serving as the Secretary.

This is the first year we are holding our annual meeting in a virtual-only format and are pleased to offer our stockholders the same opportunities to participate as provided during our past in-person meetings. We greatly appreciate your support and participation today.

Now I would like to introduce the members of our Board of Directors, some of whom are present online today: Dr. Zafrira Avnur; Tomer Kariv; Martijn Kleijwegt; Dr. Silvia Noiman; Ran Nussbaum; Steven Rubin; Dr. Jasbir Seehra; and Gadi Veinrib. I'd like to thank each of the Board members for their participation today and for their continued support of the company. Also with us today are Casey Griffin and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot